Human Gene BCAS1 (ENST00000688948.1_5) from GENCODE V47lift37
Description: brain enriched myelin associated protein 1, transcript variant 7 (from RefSeq NM_001366298.2)
Gencode Transcript: ENST00000688948.1_5
Gencode Gene: ENSG00000064787.14_17
Transcript (Including UTRs)
Position: hg19 chr20:52,560,080-52,687,133 Size: 127,054 Total Exon Count: 13 Strand: -
Coding Region
Position: hg19 chr20:52,561,461-52,675,257 Size: 113,797 Coding Exon Count: 12
Data last updated at UCSC: 2024-08-22 23:36:26
Sequence and Links to Tools and Databases
Primer design for this transcript
MalaCards Disease Associations
Comparative Toxicogenomics Database (CTD)
The following chemicals interact with this gene
Common Gene Haplotype Alleles
Press "+" in the title bar above to open this section.
Microarray Expression Data
Press "+" in the title bar above to open this section.
mRNA Secondary Structure of 3' and 5' UTRs
The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.
Orthologous Genes in Other Species
Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
Descriptions from all associated GenBank mRNAs
CR749643 - Homo sapiens mRNA; cDNA DKFZp686B1850 (from clone DKFZp686B1850).AK225656 - Homo sapiens mRNA for breast carcinoma amplified sequence 1 variant, clone: STM04831.BC024044 - Homo sapiens breast carcinoma amplified sequence 1, mRNA (cDNA clone MGC:20133 IMAGE:4645428), complete cds.AF041260 - Homo sapiens AIBC1 (AIBC1) mRNA, complete cds.JD267810 - Sequence 248834 from Patent EP1572962.JD287237 - Sequence 268261 from Patent EP1572962.JD503217 - Sequence 484241 from Patent EP1572962.JD284297 - Sequence 265321 from Patent EP1572962.JD111694 - Sequence 92718 from Patent EP1572962.JD509482 - Sequence 490506 from Patent EP1572962.JD516426 - Sequence 497450 from Patent EP1572962.JD366144 - Sequence 347168 from Patent EP1572962.JD452565 - Sequence 433589 from Patent EP1572962.JD365224 - Sequence 346248 from Patent EP1572962.JD451711 - Sequence 432735 from Patent EP1572962.JD534489 - Sequence 515513 from Patent EP1572962.JD292445 - Sequence 273469 from Patent EP1572962.JD501351 - Sequence 482375 from Patent EP1572962.JD348518 - Sequence 329542 from Patent EP1572962.JD312744 - Sequence 293768 from Patent EP1572962.JD171108 - Sequence 152132 from Patent EP1572962.JD137542 - Sequence 118566 from Patent EP1572962.BC126346 - Homo sapiens breast carcinoma amplified sequence 1, mRNA (cDNA clone MGC:161624 IMAGE:8992062), complete cds.BC126348 - Homo sapiens breast carcinoma amplified sequence 1, mRNA (cDNA clone MGC:161626 IMAGE:8992064), complete cds.JD201867 - Sequence 182891 from Patent EP1572962.JD394524 - Sequence 375548 from Patent EP1572962.JD056306 - Sequence 37330 from Patent EP1572962.JD061861 - Sequence 42885 from Patent EP1572962.JD079539 - Sequence 60563 from Patent EP1572962.JD117525 - Sequence 98549 from Patent EP1572962.JD208600 - Sequence 189624 from Patent EP1572962.JD158748 - Sequence 139772 from Patent EP1572962.JD508424 - Sequence 489448 from Patent EP1572962.JD145898 - Sequence 126922 from Patent EP1572962.JD511645 - Sequence 492669 from Patent EP1572962.JD286861 - Sequence 267885 from Patent EP1572962.AK294135 - Homo sapiens cDNA FLJ50468 complete cds, highly similar to Breast carcinoma amplified sequence 1.AK316038 - Homo sapiens cDNA, FLJ78937 complete cds, highly similar to Rattus norvegicus breast carcinoma amplified sequence 1 (Bcas1), mRNA.JD543591 - Sequence 524615 from Patent EP1572962.JD144691 - Sequence 125715 from Patent EP1572962.JD395783 - Sequence 376807 from Patent EP1572962.JD543590 - Sequence 524614 from Patent EP1572962.JD497900 - Sequence 478924 from Patent EP1572962.JD500596 - Sequence 481620 from Patent EP1572962.AK294150 - Homo sapiens cDNA FLJ50470 complete cds, moderately similar to Rattus norvegicus breast carcinoma amplified sequence 1 (Bcas1), mRNA.JD343261 - Sequence 324285 from Patent EP1572962.JD102610 - Sequence 83634 from Patent EP1572962.JD247991 - Sequence 229015 from Patent EP1572962.AK295318 - Homo sapiens cDNA FLJ50522 complete cds, highly similar to Breast carcinoma amplified sequence 1.JD500753 - Sequence 481777 from Patent EP1572962.JD255071 - Sequence 236095 from Patent EP1572962.JD208138 - Sequence 189162 from Patent EP1572962.KJ905966 - Synthetic construct Homo sapiens clone ccsbBroadEn_15636 BCAS1 gene, encodes complete protein.AK315220 - Homo sapiens cDNA, FLJ96216, highly similar to Homo sapiens breast carcinoma amplified sequence 1 (BCAS1), mRNA.HQ258323 - Synthetic construct Homo sapiens clone IMAGE:100072632 breast carcinoma amplified sequence 1 (BCAS1) (BCAS1) gene, encodes complete protein.HQ258554 - Synthetic construct Homo sapiens clone IMAGE:100072983 breast carcinoma amplified sequence 1 (BCAS1) (BCAS1) gene, encodes complete protein.KJ897863 - Synthetic construct Homo sapiens clone ccsbBroadEn_07257 BCAS1 gene, encodes complete protein.AK311215 - Homo sapiens cDNA, FLJ18257.AK308384 - Homo sapiens cDNA, FLJ98332.AK304213 - Homo sapiens cDNA FLJ52050 complete cds, highly similar to Breast carcinoma amplified sequence 1.JD436489 - Sequence 417513 from Patent EP1572962.JD187565 - Sequence 168589 from Patent EP1572962.JD439874 - Sequence 420898 from Patent EP1572962.JD060387 - Sequence 41411 from Patent EP1572962.
Other Names for This Gene
Alternate Gene Symbols: A0A8I5KUN3, A0A8I5KUN3_HUMAN, BCAS1 , hCG_37358 , NM_001366298, uc330sth.1, uc330sth.2UCSC ID: ENST00000688948.1_5RefSeq Accession: NM_001366298.2
Gene Model Information
Click here
for a detailed description of the fields of the table above.
Methods, Credits, and Use Restrictions
Click here
for details on how this gene model was made and data restrictions if any.